Table 1. Patient characteristics.

Patient no.	Age	Gender	Eye	Duration of symptoms (weeks)	Preoperative lens status	Axial length (μm)	Operative procedure	Inverted ILM flap	Tamponade	Preoperative BCVA (decimal)
1	78	F	R	28	Phakic	27.14	PPV, PEA, IOL	−	C3F8	0.09
2	71	F	R	16	IOL	27.24	PPV	+	SF6	0.02
3	77	F	R	24	IOL	28.49	PPV	−	SF6	0.02
4	50	F	L	8	IOL	31.22	PPV	−	C3F8	0.5
5	74	F	L	2	Phakic	28.72	PPV, PEA, IOL	−	C3F8	0.04
6	77	F	R	4	Phakic	31.61	PPV, PEA, IOL	+	C3F8	0.03
7	82	F	R	4	IOL	28.34	PPV	+	SF6	0.3
8	64	M	R	4	Phakic	29.74	PPV	+	SF6	0.5
9	68	M	R	2	IOL	31.14	PPV	−	C3F8	0.05
10	74	F	L	16	IOL	29.14	PPV	−	C3F8	0.09
11	73	F	R	48	IOL	31.4	PPV	−	C3F8	0.3
12	46	F	R	6	IOL	30.06	PPV	−	C3F8	0.2
13	79	F	L	1	IOL	34.37	PPV	+	SF6	0.06
14	54	M	R	4	Phakic	33.63	PPV, PEA, IOL	−	SF6	0.1
15	77	F	L	12	IOL	31.56	PPV	+	C3F8	0.1

Abbreviations: BCVA, best-corrected visual acuity; C₃F₈, perfluoropropane; F, female; ILM, internal limiting membrane; IOL, intraocular lens; M, male; PPV, pars plana vitrectomy; PEA, phacoemulsification; SF₆, sulfur hexafluoride.